Last Updated: August 9, 2026

Details for Patent: 7,458,372

Name: Drug Patent Intelligence for US Patent 7458372
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,458,372

Title:	Inhalation therapy device
Abstract:	The invention relates to an inhalation therapy device including a membrane aerosol generator. A detection device is provided for determining whether a liquid to be atomized is available. In the absence of liquid, the activation of the membrane aerosol generator is interrupted and/or a signal is output.
Inventor(s):	Franz Feiner, Markus Borgschulte, Wolfgang Achtzehner, Eduard Kunschir, Joseph Lass
Assignee:	PARI Pharma GmbH
Application Number:	US10/533,430
Patent Claim Types: see list of patent claims	Use; Device;

Drugs Protected by US Patent 7,458,372

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 7,458,372

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	102 50 625	Oct 30, 2002

PCT Information
PCT Filed	October 30, 2003	PCT Application Number:	PCT/EP03/12076
PCT Publication Date:	May 13, 2004	PCT Publication Number:	WO2004/039442

International Family Members for US Patent 7,458,372

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	453424	⤷ Start Trial
Germany	10250625	⤷ Start Trial
Germany	50312299	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.